Background/Aims: Myocardial apoptosis is heavily implicated in the myocardial injury caused by coronary microembolization (CME), and toll-like receptor 4 (TLR4) is considered to be involved in this apoptotic cascade. Therefore, the present study was designed to investigate the role of TLR4/NF-κB signaling pathway regulated by TAK-242, a selective TLR4 signal transduction inhibitor, in the myocardial apoptosis after CME in rats. Methods: Fortyfive rats were randomized (random number) into three groups: sham, CME and CME + TAK-242 (n = 15 per group).CME was induced by injecting polyethylene microspheres (42µm) into the left ventricular except the sham group. CME + TAK-242 group was treated with TAK-242 (2mg/kg) via the tail vein 30 minutes before CME modeling. Cardiac function was evaluated 6 hours after operation. Tissue biopsy was stained with HBFP to measure the size of microinfarction area. TUNEL staining was used to detect myocardial apoptosis. Western blot and qPCR were used to evaluate the expression of TLR4, MyD88, NF-κB p65, p-IκBα and Cleaved caspase-3. Results: Cardiac function in the CME group and CME + TAK-242 group were significantly decreased compared with the sham group (P < 0.05) and the micro-infarction area, the apoptotic index, the expression of TLR4, NF-κB p65, p-IκBα and Cleaved caspase-3 were increased significantly (P < 0.05). Cardiac function in the CME + TAK-242 group was significantly improved compared with the CME group (P < 0.05) and the micro-infarction area, the apoptotic index, the expression of TLR4, MyD88, NF-κB p65, p-IκBα and Cleaved caspase-3 were decreased significantly (P < 0.05). Conclusions: TAK-242 can effectively improve CMEinduced cardiac dysfunction by regulating TLR4/NF-κB signaling pathway and then reducing the myocardial apoptosis.
Introduction
Coronary microembolization (CME) was first identified at autopsy of patients dying from a sudden cardiac event [1] . As one of unfavorable complications of percutaneous coronary intervention (PCI), CME may result in myocardial micro-necrosis, cardiac dysfunction, arrhythmias, and coronary reserve reduction [2] [3] [4] . It is responsible for the lost benefit of reperfusion therapy, including thrombolytic therapy and coronary interventions. Considerable efforts have been made to prevent and treat CME, but it appears to have little effect [5] [6] [7] . Recently, some researches showed that myocardial apoptotic process may underlie the molecular mechanism of CME-induced myocardial injury [8, 9] . Apoptosis inhibition may delay the progression of chronic cardiac dysfunction following CME and improve the prognosis [10] .
Toll-like receptors play a pivotal role in host immune defense against invading pathogens and endogenous danger signals in various tissues including the heart [11, 12] . Toll-like receptor 4 (TLR4) has been demonstrated to mediate myocardial ischemia reperfusion injury, maladaptive left ventricular remodeling and increased area of myocardial infarction [13, 14] . Some researches showed that TLR4 signaling pathway may be a promising therapeutic target for the treatment of atherosclerotic cardiovascular diseases [15] [16] [17] . In our previous vitro study, we found that the activation of TLR4/ NF-κB signaling pathway trigger the apoptotic cascades and pretreatment with TAK-242, a selective TLR4 signal transduction inhibitor, then significantly suppressed cardiomyocyte apoptosis [18] . A better molecular understanding of these apoptotic properties in vivo is critical in understanding CME-induced myocardial injury and future treatment.
In the present study, we established a rat model of CME and hypothesized that treatment with TAK-242 would improve cardiac function by inhibiting the activation of TLR4/ NF-κB signaling pathway and the consequent apoptotic cascades.
Materials and Methods

Animal Modeling and Grouping
All animal procedures were conducted in accordance with the Guide for the Care and Use of Laboratory Animals (NIH Publication No. 85-23) and were approved by the Animal Care and Use Committee of Guangxi Medical University. Adult male Sprague-Dawley rats (250-300g) were provided by the Medical Experimental Animal Center of Guangxi Medical University (Nanning, China). Forty-five rats were randomized (random number) into three groups: sham, CME and CME plus TAK-242 (n = 15 per group). The present study established a CME model by injecting plastic microspheres into the left ventricle (LV), as previously described [19, 20] . Briefly, a left lateral thoracotomy was undertaken in rats at the third and fifth intercostal space. The pericardium was opened and the ascending aorta was exposed fully. A suspension of microspheres in saline solution containing about 3000 microspheres (42 µm in diameter, Biosphere Medical Inc. Rockland, USA) was injected into the LV during 10s occlusion of the ascending aorta. Rats in the CME plus TAK-242 group received an intravenous injection of TAK-242 (2 mg/kg, MedChem Express, Princeton, USA) via the tail vein 30min before surgery [21] , and rats in the sham group received an injection of the same volume of normal saline only.
Cardiac Function Monitoring
Our previous research revealed that cardiac function reached the poorest at 6h after CME, so we selected that time point to detect the cardiac function parameters [22] .
All echocardiographic examinations including left ventricular ejection fraction (LVEF), left ventricular fractional shortening (FS), cardiac output (CO) and left ventricular enddiastolic diameter (LVEDd) of the rats in each group were performed at a probe frequency of 10 MHz by an experienced professional physician. All measures were expressed as the average of three heart beat cycles.
Tissue sampling and sample treatment
After cardiac function detection, the hearts were arrested by injecting 2 mL 10% potassium chloride into the tail vein. The hearts were isolated and cleaned with cold normal saline immediately. The atrial appendage and atrium cordis were removed, and parts of heart ventricle were rapidly frozen in liquid nitrogen and stored at -80 °C for western blot analysis and qPCR. The others were fixed in 4% paraformaldehyde for 12 h, embedded in paraffin and serially sectioned into slices of 4 μm thickness for TUNEL staining and hematoxylin-basic fuchsin-picric acid (HBFP) staining.
Myocardial micro-infarct size measurement
Early myocardial ischemia or infarct region can be detected by HBFP staining. The normal myocardial tissue was dyed yellow or brown while the ischemia or necrotic myocardial tissue red. A DMR-Q550 pathological image analyzer (Leica, Germany) was used to analyze HBFP-stained slices. Briefly, five microscopic visual fields (magnification, x 100) were randomly sampled from each slice for observation using Leica Qwin analysis software. The area of micro-infarction was determined by planimetry and expressed as percentage of the total analyzed area.
Apoptosis assay
Apoptotic cardiomyocytes were detected using TUNEL assay kit (Roche, USA). TUNEL staining was performed according to the manufacturer's instructions. The apoptotic nuclei were stained yellow-brown while the normal light blue. In each slice,10 random high-power fields (magnification, x 400) were observed to count TUNEL-positive nuclei, and the myocardial apoptotic index was calculated as the number of TUNELpositive cell nuclei / total nuclei ×100%.
RNA extraction and Quantitative RT-PCR
Total RNA was extracted from cardiac tissue using the TRIzol reagent (Gibco, USA) according to the protocols supplied by the manufacturers. The concentration of RNA was quantified by a NanoDrop (Thermo Fisher Scientific Inc., USA) and then subjected to reverse transcription using a cDNA reverse transcription kit (TaKaRa, Japan) according to the manufacturer's instructions. Then, the obtained cDNA was subjected to RT-qPCR for TLR4 mRNA using a SYBR Green I PCR kit (TaKaRa, Japan). The conditions for all RT-qPCR reactions were performed on the ABI PRISM 7500 system (Applied BioSystems, USA). The sequences of the primers were designed as follows: TLR4 forward: 5′-AAGTTATTGTGGTGGTGTCTAG-3′ and reverse: 5′-GAGGTAGGTGTTTCTGCTAAG-3′; GAPDH forward: 5′-TGCACCACCAACTGCTTAG-3′ and reverse: 5′-GATGCAGGGATGATGTTC-3′. The relative quantification of TLR4 mRNA expression was calculated using the 2 -∆∆Ct method and was normalized to GAPDH.
Western blotting
The protein samples were extracted from cardiac tissue blocks with Protein Extracion Kit (Solarbio, Beijing, China). The protein concentrations were determined by using a bicinchoninic acid (BCA) protein assay (Beyotime Biotechnology, Jiangsu, China). Each sample containing equal amounts (50 μg) of protein was loaded on 10% SDS-PAGE and transferred to a PVDF membrane (Millipore). After blocking with 5% non-fat milk in TBS for 1 h at room temperature, membranes were incubated with the following primary antibodies in dilution buffer overnight at 4 °C: anti-TLR4, anti-MyD88, anti-NF-κB (p65), anti-p-IκBα, anticleaved caspase-3, anti-Histone-H3 and anti-GAPDH (all from Abcam, Cambridge, USA). GAPDH was used as an internal control and Histone-H3 was used as a nuclear protein loading control. After washing 3 times in TBST, the membranes were incubated with goat anti-mouse horseradish peroxidase (HRP)-conjugated secondary antibodies (KeyGEN BioTECH, Nanjing, China) in dilution buffer for 2 h at room temperature. Then, antigen-antibody complex was visualized using the enhanced chemiluminescence (ECL) method. Immunoblots were exposed to X-ray film and images were taken using an imaging system (Bio-Rad, USA). At last, the results were analyzed using the Quantity One software (Bio-Rad).
Statistical analysis
All data are presented as mean ± standard deviation (SD). Differences between multiple groups were analyzed by one-way ANOVA followed by Student-Neuman-Keuls or Dunnett test, using Prism software (GraphPad Prism version 5.0). All experiments were performed independently in triplicate. Values of P < 0.05 were considered as statistically significant.
Results
Changes in cardiac function
Compared to the sham group, cardiac dysfunction was induced following CME, characterized by increased LVEDD as well as decreased LVEF, FS, and CO (P < 0.05) as summarized in Table 1 . Pretreatment with TAK-242 significantly improved cardiac function following CME, as compared to the CME model group (P < 0.05). These results suggest that pretreatment with TAK-242 improves cardiac function in this rat model of CME.
Micro-infarct Following CME HBFP staining was performed to determine the presence of myocardial micro-infarction (Fig. 1) . No micro-infarct was found in the sham group, while it was significantly evident in the CME group (P < 0.05). TAK-242 pretreatment group significantly reduced the microinfarction area, as compared to the CME model group (8.58±2.12 vs. 14.65±4.23, P < 0.05).
Myocardial apoptosis following CME TUNEL staining was conducted to confirm myocardial apoptosis. The myocardial apoptotic index in the sham, CME and CME plus TAK-242 groups were 1.90±0.80 %, 33.6±6.30 % and 14.3±5.10 %, respectively (Fig. 2) . The apoptotic index was significantly enhanced in the CME group compared with the sham group (P < 0.05). TAK-242 pretreatment significantly reduced apoptotic index (P < 0.05).
Expression of TLR4 mRNA
RT-qPCR analysis was performed to observe the expression of TLR4 mRNA in rat myocardial (Fig. 3) . Compared with the rats from the sham group, those from the CME group showed significantly enhanced expression of myocardial TLR4 mRNA after CME modeling (P < 0.05). Meanwhile, the mRNA levels of TLR4 were significantly down-regulated by pretreatment with TAK-242 (P < 0.05). The results of western blot analysis were consistent with RT-qPCR analysis (Fig. 4) . Table 1 . Effects of TAK-242 on cardiac function following CME. Abbreviations: CME, coronary microembolization; LVEF, left ventricular ejection fraction; FS, left ventricular fractional shortening; CO, cardiac output; LVEDd, left ventricular enddiastolic diameter. Data are presented as mean ± S.D.
a P < 0.05 versus the sham group; b P < 0.05 versus the CME group a P < 0.05 versus the sham group; b P < 0.05 versus the CME group.
Discussion
The present study was designed to explore the role of TLR4/NF-κB signaling pathway regulated by TAK-242 in the myocardial apoptosis after CME in rats. The results revealed that cardiac dysfunction, micro-infarct and apoptosis were induced following CME. Additionally, our results showed that the activation of TLR4/NF-κB signaling pathway was a potential mechanism for CME-induced myocardial apoptosis in rats. The TLR4 inhibitor, TAK-242, effectively improved CME-induced cardiac dysfunction by regulating TLR4/NF-κB signaling pathway and then reducing the myocardial apoptosis. a P < 0.05 versus the sham group; b P < 0.05 versus the CME group. b P < 0.05 versus the CME group. CME is defined as coronary microcirculation thrombosis and micro-infarction caused by atherosclerotic plaque rupture or microemboli in patients undergoing PCI [3] . It may occur spontaneously in patients with acute coronary syndromes or artificially during thrombolytic therapy and coronary interventions, resulting in serious sequelae such as malignant arrhythmias, contractile dysfunction and even sudden cardiac death [1, 23] .
Toll-like receptors play a pivotal role in host immune defense against invading pathogens and endogenous danger signals in various tissues including the heart [11, 12] .TLR4 has been demonstrated to mediate myocardial ischemia reperfusion injury, maladaptive left ventricular remodeling and increased infarct size after myocardial infarction [13, 14, 24, 25] . Some research findings suggest that the activation of TLR4 signaling pathway is considered to be a promising therapeutic target for the treatment of atherosclerotic cardiovascular diseases [16, 26, 27] . In the present study, we revealed that the mRNA and protein levels of TLR4 were up-regulated after CME in rats.
In this study, CME-induced myocardial apoptosis is reduced by pretreatment with TAK-242, an exogenous synthetic antagonist for TLR4, suggesting that the TLR4 pathway plays a critical role in CME-induced apoptosis. Apoptosis in the present study was documented by TUNEL staining. The results were consistent with characteristic changes of cleaved caspase-3 protein, a marker of apoptosis.
MyD88 and NF-κB are the downstream effectors of TLR4, which regulate the expression of many inflammatory genes and participate in the development of atherosclerosis [28, 29] . NF-κB activation is pivotal in the transcription and translation of caspases expression. In addition, NF-κB plays a crucial role in cardiac pathological processes via regulating expression of many genes that are involved in apoptosis of cardiomyocytes [30] . Research data in vitro and vivo suggested the potential importance of TLR4/NF-κB pathway in myocardial ischemia-reperfusion injury [27, 30] . Therefore, inhibition of TLR4-mediated NF-κB activation could be an important approach for attenuation of cardiac dysfunction.
Caspases play a vital role in the regulation and execution of apoptosis. We determined the activation of caspase-3 in the present study to examine downstream apoptotic signaling during CME-induced apoptosis. Caspase-3 catalyzes a terminal step in apoptosis, and its activation may serve as a marker of apoptosis in heart [31] . The results of the present study showed that CME significantly increased the activation of caspase-3 in rat hearts.
The present study predominantly focused on CME induced myocardial injury and investigated the possible underlying mechanisms. CME induced myocardial injury was shown to be associated with TLR4/NF-κB signaling pathway activation induced myocardial apoptosis. These findings may provide new therapeutic options for myocardial injury in CME-induced cardiac dysfunction.
For better interpretation of the results, some limitations in this study should be acknowledged. First, the results were derived from rat CME model which was made by injecting plastic microspheres into the LV. Therefore, the current results may not be directly comparable with those obtained in vivo microembolization in patients. Second, we only investigated the short-term protective effects of TAK-242. Thus, it is uncertain how long would this protective effect sustain. Considering of this, future studies are therefore required to explore in more accurately mimic animal model.
In conclusion, our results indicate that CME induces myocardial apoptosis in a rat model via the activation of TLR4/NF-κB signaling pathway. TAK-242 can effectively improve CME-induced cardiac dysfunction by regulating TLR4/NF-κB signaling pathway and then reducing the myocardial apoptosis.
